Regulation of Brain Glucose Metabolism in Type 1 Diabetes (NCT05317455)

🧪 Interventions in This Study

• Dichloroacetate (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Yale-New Haven Hospital — New Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (475) 321-0504

Email: alice.hahn@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetes Mellitus, Type 1

• Testing an Integrated Care Model Trial — Atlanta, Georgia
• Safety of ENC-201-CED ENCRT — Toronto, Ontario
• Teplizumab in Pediatric Stage 2 Type 1 Diabetes — San Francisco, California
• Allogenic Islet Cell Transplantation — Chicago, Illinois
• Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells — Charleston, South Carolina
• Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes — Stanford, California

Explore by condition: All Diabetes Mellitus, Type 1 clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.